| Patents for C07K 7 - Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof (42,273) |
|---|
| 05/16/2007 | CN1315870C Peptide and compounds that bind to receptor |
| 05/15/2007 | US7217785 Genetic engineered apolipoproteins with phsophatide surface treatment; cardiovascular disorders, antiischemic agents, bone disorders, antiinflammatory agents |
| 05/15/2007 | US7217694 Inhibitors of IAPP fibril formation and uses thereof |
| 05/15/2007 | US7217690 Administering to the mammal an effective amount of one or more cyclic peptides for treating a skin irritation |
| 05/15/2007 | US7217507 Using affinity chromatography to characterize and isolated ligand and bindng partner complexes |
| 05/15/2007 | CA2176948C Chaperonin 10 |
| 05/15/2007 | CA2094705C Pharmaceutical composition for treating or preventing malign tumors |
| 05/15/2007 | CA2065414C Treatment of autoimmune disease |
| 05/15/2007 | CA2011633C Intercellular adhesion molecule - 2 and its binding ligands |
| 05/10/2007 | WO2007053644A2 Comparative ligand mapping from mhc class i positive cells |
| 05/10/2007 | WO2007052854A1 Use of the gonadotropin-releasing hormone ii antagonists and its analogues |
| 05/10/2007 | WO2007051317A1 Compositions and methods for treating atherosclerosis |
| 05/10/2007 | WO2006039326A3 Inhibitors of hepatitits c virus |
| 05/10/2007 | US20070106064 Solid phase method for synthesis peptide-spacer-lipid conjugates, conjugates synthesized thereby and targeted liposomes containing the same |
| 05/10/2007 | US20070106062 Attenuated vif DNA immunization cassettes for genetic vaccines |
| 05/10/2007 | US20070105781 Inhibitors of serine proteases |
| 05/10/2007 | US20070105779 Isolated, ssx-2 and ssx-2 related peptides useful as hla binders and ctl epitopes, and uses thereof |
| 05/10/2007 | US20070105778 Methods of screening molecular libraries and active molecules identified thereby |
| 05/10/2007 | US20070105760 Process for the preparation of echinocandin derivatives |
| 05/10/2007 | US20070105759 Melanocortin receptor 4 (mc4) agonists and their uses |
| 05/10/2007 | US20070105131 Sequencing of surface immobilized polymers utilizing microfluorescence detection |
| 05/10/2007 | DE102005051978A1 Verfahren zur Bestimmung der Spaltbarkeit von Substraten Method for determining the cleavage of substrates |
| 05/10/2007 | DE102005051977A1 Neue 2,4-Dichlorphenoxyessigsäurederivate und deren Verwendung in diagnostischen und analytischen Nachweisverfahren New 2.4-dichlorophenoxyacetate and their use in diagnostic and analytical detection method |
| 05/10/2007 | CA2626868A1 Novel protein transduction domains and uses therefor |
| 05/09/2007 | EP1783141A1 Antigen-binding fragments specific for dendritic cells, compositions and methods of use thereof antigens recognized thereby and cells obtained thereby |
| 05/09/2007 | EP1783139A2 Human telomerase catalytic subunit |
| 05/09/2007 | EP1782833A2 pH-sensitive polymeric conjugates of an anthracycline cancerostatic drug for targeted therapy |
| 05/09/2007 | EP1782820A1 Method of screening toxin-neutralizing peptide, stx2 inhibitory peptide and vero toxin-neutralizing agent |
| 05/09/2007 | EP1781780A2 Treating cancer |
| 05/09/2007 | EP1781689A1 Conjugates and therapeutic uses thereof |
| 05/09/2007 | EP1781685A1 Therapeutic and diagnostic agents |
| 05/09/2007 | EP1781316A2 Cyclic peptides for treatment of cachexia |
| 05/09/2007 | EP1073447B1 N1-modified glycopeptides |
| 05/09/2007 | EP0793675B9 Hiv-1- and hiv-2-peptides for inhibition of membrane fusion-associated events, including hiv transmission |
| 05/09/2007 | CN1961001A Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins |
| 05/09/2007 | CN1958614A Fusion protein of chemoattracting small peptide and dual specific antibodies |
| 05/09/2007 | CN1314706C Antigen epitope II of neutrality B cell of chicken IBDV VP2 protein and application thereof |
| 05/09/2007 | CN1314705C Peptide for high performance inhibition of angiogenesis and method for preparing same and use thereof |
| 05/09/2007 | CN1314704C Oligopeptide suppressor of matrix metalloprotease 2 |
| 05/08/2007 | US7214785 isolating novel anti-FVIII inhibitor antibodies distinctly having specificity and the inhibitor activity to FVIII from lymphocytes of a patient by the antibody display phage technology and analyzed the VH and VL chains of said specific antibodies |
| 05/08/2007 | US7214768 Echinocandin process |
| 05/08/2007 | US7214766 Peptides with enhanced stability to protease degradation |
| 05/08/2007 | US7214657 Method of transporting a chimeric hybrid molecule across the blood brain barrier |
| 05/08/2007 | US7214655 Artificial tanning |
| 05/08/2007 | CA2185489C Cyclic adhesion inhibitors |
| 05/03/2007 | WO2007049905A1 Peptides for promoting hair growth and improving wrinkle and cosmetic compositions comprising the same |
| 05/03/2007 | WO2007049805A1 Synthetic lipopeptide and use thereof for medical purposes |
| 05/03/2007 | WO2007049803A1 New cyclic peptide compounds |
| 05/03/2007 | WO2007049737A1 Cytotoxic t-cell epitope peptide capable of specifically attacking cell infected with epstein-barr virus |
| 05/03/2007 | WO2007049731A1 Novel cell membrane-permeable peptide |
| 05/03/2007 | WO2007049635A1 Process for production of peptide thioester |
| 05/03/2007 | WO2007049394A1 Peptides originating in hepatitis c virus |
| 05/03/2007 | WO2007048830A2 Assays for histone deacetylase 1/2 selective inhibitors |
| 05/03/2007 | WO2007030937A3 Screening proteinase modulators using a chimeric protein and ski-i proprotein convertase substrates and inhibitors |
| 05/03/2007 | WO2007020405A3 Integrin i-domain binding peptides |
| 05/03/2007 | WO2002081649A3 ErbB INTERFACE PEPTIDOMIMETICS AND METHODS OF USE THEREOF |
| 05/03/2007 | US20070101448 Synthetic single domain polypeptides mimicking apolipoprotein E and methods of use |
| 05/03/2007 | US20070099885 Antibacterial macrocycles with substituted biphenyl |
| 05/03/2007 | US20070099842 Tripeptides and derivatives thereof for cosmetic application in order to improve skin structure |
| 05/03/2007 | US20070099839 Inhibitors of cell migration |
| 05/03/2007 | US20070099244 Specific binding sites in collagen for integrins and use thereof |
| 05/03/2007 | US20070099240 Pixel arrays |
| 05/03/2007 | US20070099182 Comparative ligand mapping from MHC class I positive cells |
| 05/03/2007 | CA2623898A1 New cyclic peptide compounds |
| 05/02/2007 | EP1780215A1 Crohn"s disease antibody epitope peptide and reagent for testing crohn"s disease |
| 05/02/2007 | EP1779859A2 Use of depsipeptide and congeners thereof as immunosuppressants in preventing or treating rejection following transplantation and for induction of apoptosis of activated CD4 or CD8 T-cells |
| 05/02/2007 | EP1778720A2 Antimicrobial peptides comprising an arginine- and/or lysine-containing motif |
| 05/02/2007 | EP1778719A1 Supertype epitopes, oligonucleotides coding the same which induce effective ctl response against hcv and the use thereof |
| 05/02/2007 | EP1778651A2 Multivalent chelators for modifying and organizing of target molecules |
| 05/02/2007 | EP1778299A2 Methods for preparing multivalent constructs for therapeutic and diagnostic applications |
| 05/02/2007 | EP1077721B1 Prevention and treatment of hypergastrinemia |
| 05/02/2007 | CN1956994A Epithelial cell growth promoter |
| 05/02/2007 | CN1313484C 12 amino acid analog epi-position of human B cell specificity membrane molecule CD20 and polypeptide epi-position vaccine configurated by said analog epi-position |
| 05/02/2007 | CN1313483C Inhibitory peptide of YMDD domain of duck hepatitis-B virus polymerase protein and application thereof |
| 05/02/2007 | CN1313482C Inhibition peptide of hepatatitis B virus polyzymoprotein YMDD functional region and its application |
| 05/02/2007 | CN1313481C Isolated nona- and decapeptides which bind to HLA molecules, and the use thereof |
| 05/02/2007 | CN1313149C Use of compounds having the biological activity of vasoactive intestinal peptide for the treatment of sarcoidosis |
| 05/02/2007 | CN1313146C Methods and compositions useful for inhibition of 'alpha'v'beta'5 mediated angiogenesis |
| 05/02/2007 | CN1313082C Slow releasing composition and its preparing method |
| 05/01/2007 | USRE39606 Synthetic libraries of random oligomers, each member comprising an oligomer linked to a microchip encoded with information identifying structure of oligomer, for drug screening |
| 05/01/2007 | US7211566 a nonapeptide analog; antiinflammatory, antidiabetic agents, analgesics, antiastmatic agents |
| 05/01/2007 | US7211565 a 15 to 22-residue polypeptide analog that forms an amphipathic alpha helix in the presence of lipids; anticholesterol agents; hypercholesterolemia, cardiovascular disorders, atherosclerosis, restenosis, hypertriglyceridemia, high density lipoprotein deficiency, metabolic disorders |
| 05/01/2007 | US7211424 Mammalian Subtilisin/kexin isozyme SKI-1: a proprotein convertase with a unique cleavage specificity |
| 05/01/2007 | US7211395 Serum albumin conjugate for use in the transfer and delivery of therapeutic agent to target |
| 05/01/2007 | US7211240 Multivalent constructs for therapeutic and diagnostic applications |
| 05/01/2007 | CA2296036C Dolastatin 15 derivatives |
| 05/01/2007 | CA2185394C Biotinderivate |
| 05/01/2007 | CA2121497C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 05/01/2007 | CA2120303C Cyclic adhesion inhibitors |
| 05/01/2007 | CA2081704C Biosynthetic process for the preparation of lantibiotics |
| 04/26/2007 | WO2007048120A2 Treatment of proliferative disorders with polycationic agents |
| 04/26/2007 | WO2007047608A2 Fibrin targeted therapeutics |
| 04/26/2007 | WO2007047521A2 A polypeptide molecular switch |
| 04/26/2007 | WO2007004060A3 Cytokine receptor modulators and uses thereof |
| 04/26/2007 | WO2006050930A3 Conjugates with enhanced cell uptake activity |
| 04/26/2007 | US20070093645 Peptide vectors |
| 04/26/2007 | US20070093428 IAP BIR domain binding compounds |
| 04/26/2007 | US20070093427 Membrane-permeable NFAT inhibitory peptide |
| 04/26/2007 | US20070093426 Peptides from amino acid residues of human histone H2A: thermal burns, chemical burns, autoimmune diseases, arthritis, multiple sclerosis |
| 04/26/2007 | US20070093425 Improved safety and stability and excellent percutaneous permeability; 6-(succinyl-glycyl-histidyl-lysine)ascorbic acid; cosmetics; for topical application to the skin |